Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00560794
Brief Title: Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

First Submitted : November 19, 2007
First Submitted that Met QC Criteria : November 19, 2007
First Posted : November 20, 2007 (Estimate)

Results First Submitted : December 23, 2014
Results First Submitted that Met QC Criteria : December 23, 2014
Results First Posted : January 7, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : January 12, 2015
Last Update Posted : January 26, 2015 (Estimate)